In-vitro Diagnostics Market Outlook in Australia

 


This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood glucose, and point-of-care testing, and forecasts the same until 2017. Regional attractiveness and analysis based on competitive forces are provided. In addition, the future market potential and opportunities in attractive segments are discussed in detail.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

In-vitro Diagnostics Market Outlook in Australia, Executive SummarySummary of the Australian IVD MarketTitleDisclaimerCertificationTable of ContentsList of FiguresList of ChartsOverview of the Australian IVD MarketIn-vitro Diagnostics Market Outlook in Australia, Research OverviewOverview of this ResearchResearch Objective and MethodologyHealthcare Structure - AustraliaIVD Products - Approval Reimbursement and ProcurementRegulation of IVD ProductsIVD Pricing Schedule from 1 July 2010Definitions and AbbreviationsScope and SegmentationIn-vitro Diagnostics Market Outlook in Australia, Industry ChallengesKey Industry ChallengesIdentification of Key Industry ChallengesAnalysis of the Total Australian IVD MarketMarket Engineering Forecasts for the Australian IVD MarketMarket OverviewMarket Engineering MeasurementsMarket Drivers and RestraintsMarket LifecycleRevenue Forecasts - Total IVD MarketPercent of Revenues by SegmentMarket Engineering Forecasts for the Clinical Chemistry MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the Immunoassay MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the Hematology MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the Coagulation MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the Microbiology MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the Molecular Diagnostics MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the SMBG MarketRevenue ForecastsCurrent StatusMarket Engineering Forecasts for the POCT MarketRevenue ForecastsCurrent StatusMarket CompetitionCompetitive StructureCompetitive ScenarioMarket Share AnalysisFuture OutlookIVD Business in AustraliaCustomer Priorities TrajectorySnapshot of Potential OpportunitiesMarket AttractivenessOpportunities in Attractive SegmentsKey Trends and OpportunitiesImpact of Top Four Trends on the Market GrowthConclusion and RecommendationsDatabase of Key Participants in the Australian IVD MarketDatabase of Key Market Participants - Manufacturers and DistributorsList of Major Laboratories and Their LocationIn-vitro Diagnostics Market Outlook in Australia, About Frost & SullivanShort Summary about Frost & SullivanWhat we do?




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.